1. Van der Kwast TH, Schalken J, Ruizeveld de Vinter JA, van Vroonhoven CC, Mulder E, Boersma W, Trapman J (1991) Androgen receptors in endocrine therapy-resistant human prostate cancer. Int J Cancer 48:188–193
2. Hobisch A, Culig Z, Radmayr C, Bartsch G, Klocker H, Hittmair A (2005) Distant metastases from prostatic carcinoma express androgen receptor protein. Cancer Res 55:3068–3072
3. Visakorpi T, Hyytinen E, Koivisto P, Tanner M, Keinänen R, Palmberg C, Palotie A, Tammela T, Isola J, Kallioniemi OP (1995) In vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nat Genet 9:401–406
4. Attard G, Richards J, de Bono JS (2011) New strategies in metastatic prostate cancer: targeting the androgen receptor signaling pathway. Clin Cancer Res 17:1649–1657
5. Mukherji D, Pezaro CJ, De Bono JS (2012) MDV3100 for the treatment of prostate cancer. Expert Opin Invest Drugs 21:227–233